Search Results - "Brown, Myles A"

p16INK4A-deficiency predicts response to combined HER2 and CDK4/6 inhibition in HER2+ breast cancer brain metastases by Ni, Jing, Kabraji, Sheheryar, Xie, Shaozhen, Wang, Yanzhi, Pan, Peichen, He, Xiaofang, Liu, Zongming, Leone, Jose Palbo, Long, Henry W., Brown, Myles A., Winer, Eric P., Dillon, Deborah A. R., Lin, Nancy U., Zhao, Jean J.

“…Approximately 50% of patients with metastatic HER2-positive (HER2+) breast cancer develop brain metastases (BCBMs). We report that the tumor suppressor p16…”
Get full text

Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response by Jiang, Peng, Gu, Shengqing, Pan, Deng, Fu, Jingxin, Sahu, Avinash, Hu, Xihao, Li, Ziyi, Traugh, Nicole, Bu, Xia, Li, Bo, Liu, Jun, Freeman, Gordon J., Brown, Myles A., Wucherpfennig, Kai W., Liu, X. Shirley

“…Cancer treatment by immune checkpoint blockade (ICB) can bring long-lasting clinical benefits, but only a fraction of patients respond to treatment. To predict…”
Get full text

Target-Directed Enediynes:  Designed Estramycins by Jones, Graham B, Hynd, George, Wright, Justin M, Purohit, Ajay, Plourde, Gary W, Huber, Robert S, Mathews, Jude E, Li, Aiwen, Kilgore, Michael W, Bubley, Glenn J, Yancisin, Molly, Brown, Myles A

“…The goal of selective targeting of enediyne cytotoxins has been investigated using estrogenic delivery vehicles. A series of estrogen−enediyne conjugates were…”
Get full text

Overview consensus statement by Carroll, Peter R, Kantoff, Philip W, Balk, Steven P, Brown, Myles A, D’amico, Anthony V, George, Daniel J, Grossfeld, Gary D, Johnson, Candace S, Kelly, William Kevin, Klotz, Laurence, Lee, W.Robert, Lubeck, Deborah P, Mcleod, David G, Oh, William K, Pollack, Alan, Sartor, Oliver, Smith, Matthew R, Hart, Carol

Get full text

Abstract 4759: Dissecting EP300 and CBP function in prostate cancer models by Mirpuri, Kiran, Tewari, Alok K., Brown, Myles A.

“…Abstract Prostate adenocarcincoma is dependent on androgen and its cellular receptor the androgen receptor (AR) for most of the natural history of the disease…”
Get full text

Proceedings of the Third International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: conference summary statement by Come, Steven E, Buzdar, Aman U, Arteaga, Carlos L, Bissell, Mina J, Brown, Myles A, Ellis, Matthew J, Goss, Paul E, Green, Jeffrey E, Ingle, James N, Lee, Adrian V, Medina, Daniel, Nicholson, Robert I, Santen, Richard J, Schiff, Rachel, Hart, Carol S

Get full text

Protein-Degrading Enediynes:  Library Screening of Bergman Cycloaromatization Products by Jones, Graham B, Wright, Justin M, Hynd, George, Wyatt, Justin K, Yancisin, Molly, Brown, Myles A

“…A screening method based on Bergman cycloaromatization products was applied to a compact library of estrogenic-enediyne hybrids. An enediyne candidate…”
Get full text

Abstract 3376: Reprogramming the estrogen signaling network is a potential mechanism for human breast tumorigenesis by Chi, David, Singhal, Hari, Li, Lewyn, Long, Henry W., Garber, Judy E., Brown, Myles A.

“…Abstract Background: The estrogen receptor (ER) is expressed in approximately 70% of sporadic breast cancers and is known to activate genes driving cell…”
Get full text

The Adoption of Conservation Practices and Program Participation Among Socially Disadvantaged Agricultural Producers: A Meta-Analysis by Brown, Myles A

“…As climate change has become undeniable in recent years, it has become increasingly important for the agriculture industry to address conservation. Within the…”
Get full text

p16 INK4A -deficiency predicts response to combined HER2 and CDK4/6 inhibition in HER2+ breast cancer brain metastases by Ni, Jing, Kabraji, Sheheryar, Xie, Shaozhen, Wang, Yanzhi, Pan, Peichen, He, Xiaofang, Liu, Zongming, Leone, Jose Palbo, Long, Henry W, Brown, Myles A, Winer, Eric P, Dillon, Deborah A R, Lin, Nancy U, Zhao, Jean J

“…Approximately 50% of patients with metastatic HER2-positive (HER2+) breast cancer develop brain metastases (BCBMs). We report that the tumor suppressor p16 is…”
Get full text

Proceedings of the Third International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer by Come, Steven E., Buzdar, Aman U., Arteaga, Carlos L., Bissell, Mina J., Brown, Myles A., Ellis, Matthew J., Goss, Paul E., Green, Jeffrey E., Ingle, James N., Lee, Adrian V., Medina, Daniel, Nicholson, Robert I., Santen, Richard J., Schiff, Rachel, Hart, Carol S.

Get full text

Overview consensus statement. Newer approaches to androgen deprivation therapy in prostate cancer by Carroll, Peter R, Kantoff, Philip W, Balk, Steven P, Brown, Myles A, D'amico, Anthony V, George, Daniel J, Grossfeld, Gary D, Johnson, Candace S, Kelly, William Kevin, Klotz, Laurence, Lee, W Robert, Lubeck, Deborah P, Mcleod, David G, Oh, William K, Pollack, Alan, Sartor, Oliver, Smith, Matthew R, Hart, Carol

Get full text